Epi Info

Results Library
Current View:
E:\EPIINFO\Kelompok Genap.MDB:viewKelompokGenap
Record Count: 30 (Deleted records excluded)
Date: 06/04/2016 21:19:35
FREQ *
Next Procedure
Nama
Umur
JenisKelamin
Alamat
Diagnosa
Obat1
Obat2
Obat3
Obat4
JenisJaminanKesehatan
Nama
Forward
Nama

Frequency

Percent

Cum Percent

ABD. JAFAR

3.3%

3.3%

Abd. RASYID

3.3%

6.7%

AHMAD ALAMSYAH

3.3%

10.0%

AMMANG

3.3%

13.3%

ANITA WULANDARI

3.3%

16.7%

ARIFAI

3.3%

20.0%

ARUM

3.3%

23.3%

DONI ALAMBARA

3.3%

26.7%

DUTA

3.3%

30.0%

Hj. NURDIAH

3.3%

33.3%

Hj. ZULAIHA

3.3%

36.7%

IBUSE

3.3%

40.0%

IDA LIDYA

3.3%

43.3%

INADIA

3.3%

46.7%

ISALIMANG

3.3%

50.0%

ISAPIA

3.3%

53.3%

LA TAHANG

3.3%

56.7%

LADUPPA

3.3%

60.0%

LATIPU

3.3%

63.3%

LAUPE

3.3%

66.7%

MANOHARA

3.3%

70.0%

MARLINA

3.3%

73.3%

MUH. DAMIS

3.3%

76.7%

MUHAMMAD HASBI

3.3%

80.0%

MUHLIS

3.3%

83.3%

NURUL ATIKAH

3.3%

86.7%

RATNA

3.3%

90.0%

RIO ANUGERAH

3.3%

93.3%

SHIFA

3.3%

96.7%

WAHYU SAMAD

3.3%

100.0%

30

100.0%

100.0%

Total

95% Conf Limits

ABD. JAFAR
Abd. RASYID
AHMAD ALAMSYAH
AMMANG
ANITA WULANDARI
ARIFAI
ARUM
DONI ALAMBARA
DUTA
Hj. NURDIAH
Hj. ZULAIHA
IBUSE
IDA LIDYA
INADIA
ISALIMANG
ISAPIA
LA TAHANG
LADUPPA
LATIPU
LAUPE
MANOHARA
MARLINA
MUH. DAMIS

0.1%
0.1%
0.1%
0.1%
0.1%
0.1%
0.1%
0.1%
0.1%
0.1%
0.1%
0.1%
0.1%
0.1%
0.1%
0.1%
0.1%
0.1%
0.1%
0.1%
0.1%
0.1%
0.1%

17.2%
17.2%
17.2%
17.2%
17.2%
17.2%
17.2%
17.2%
17.2%
17.2%
17.2%
17.2%
17.2%
17.2%
17.2%
17.2%
17.2%
17.2%
17.2%
17.2%
17.2%
17.2%
17.2%

MUHAMMAD HASBI
MUHLIS
NURUL ATIKAH
RATNA
RIO ANUGERAH
SHIFA
WAHYU SAMAD

0.1%
0.1%
0.1%
0.1%
0.1%
0.1%
0.1%

Umur
Back Forward Current Procedure
Umur
Frequency
Percent

Cum Percent

3.3%

3.3%

3.3%

6.7%

6.7%

13.3%

3.3%

16.7%

3.3%

20.0%

10

6.7%

26.7%

12

3.3%

30.0%

21

3.3%

33.3%

23

3.3%

36.7%

29

3.3%

40.0%

30

6.7%

46.7%

45

6.7%

53.3%

50

6.7%

60.0%

51

3.3%

63.3%

53

3.3%

66.7%

55

3.3%

70.0%

59

3.3%

73.3%

60

6.7%

80.0%

63

6.7%

86.7%

65

6.7%

93.3%

67

3.3%

96.7%

70

3.3%

100.0%

30

100.0%

100.0%

Total

95% Conf Limits

17.2%
17.2%
17.2%
17.2%
17.2%
17.2%
17.2%

2
4
5
7
9
10
12
21
23
29
30
45
50
51
53
55
59
60
63
65
67
70

0.1%
0.1%
0.8%
0.1%
0.1%
0.8%
0.1%
0.1%
0.1%
0.1%
0.8%
0.8%
0.8%
0.1%
0.1%
0.1%
0.1%
0.8%
0.8%
0.8%
0.1%
0.1%

17.2%
17.2%
22.1%
17.2%
17.2%
22.1%
17.2%
17.2%
17.2%
17.2%
22.1%
22.1%
22.1%
17.2%
17.2%
17.2%
17.2%
22.1%
22.1%
22.1%
17.2%
17.2%

JenisKelamin
Back Forward Current Procedure
JenisKelamin
Frequency

Percent

Cum Percent

Laki-laki

15

50.0%

50.0%

Perempuan

15

50.0%

100.0%

Total

30

100.0%

100.0%

Laki-laki
Perempuan

Alamat

95% Conf Limits

31.3%
31.3%

68.7%
68.7%

Back Forward Current Procedure

Alamat
Frequency
Percent

Cum Percent

Allakuang

6.7%

6.7%

Pangkajene

25

83.3%

90.0%

10.0%

100.0%

30

100.0%

100.0%

Tanete
Total

Allakuang
Pangkajene
Tanete

95% Conf Limits

0.8%
65.3%
2.1%

22.1%
94.4%
26.5%

Diagnosa
Back Forward Current Procedure
Diagnosa
Frequency

Percent

Cum Percent

Anemia Malena

3.3%

3.3%

Dermatitis

20.0%

23.3%

Gastritis

10.0%

33.3%

GEA

16.7%

50.0%

Hipertensi

30.0%

80.0%

ISPA

20.0%

100.0%

Total

30

100.0%

100.0%

Anemia Malena
Dermatitis
Gastritis
GEA
Hipertensi
ISPA

Obat1

95% Conf Limits

0.1%
7.7%
2.1%
5.6%
14.7%
7.7%

17.2%
38.6%
26.5%
34.7%
49.4%
38.6%

Back Forward Current Procedure

Obat1
Frequency

Percent

Cum Percent

Amlodipine

30.0%

30.0%

Antasida

10.0%

40.0%

Ctm

3.3%

43.3%

Dexametazone

20.0%

63.3%

Etabion

3.3%

66.7%

GG

3.3%

70.0%

Oralit

16.7%

86.7%

Pct.

13.3%

100.0%

Total

30

100.0%

100.0%

95% Conf Limits

14.7%
2.1%
0.1%
7.7%
0.1%
0.1%
5.6%
3.8%

Amlodipine
Antasida
Ctm
Dexametazone
Etabion
GG
Oralit
Pct.

49.4%
26.5%
17.2%
38.6%
17.2%
17.2%
34.7%
30.7%

Obat2
Back Forward Current Procedure
Obat2
Frequency

Percent

Cum Percent

Amox

6.7%

6.7%

Amox.

6.7%

13.3%

B. Com

30.0%

43.3%

Captopril

30.0%

73.3%

Ctm

3.3%

76.7%

GG

3.3%

80.0%

Metronidazole

3.3%

83.3%

Zink

16.7%

100.0%

Total

30

100.0%

100.0%

95% Conf Limits

0.8%
0.8%
14.7%
14.7%
0.1%
0.1%
0.1%
5.6%

Amox
Amox.
B. Com
Captopril
Ctm
GG
Metronidazole
Zink

22.1%
22.1%
49.4%
49.4%
17.2%
17.2%
17.2%
34.7%

Obat3
Back Forward Current Procedure
Obat3
Frequency
Percent

Cum Percent

B. Com

5.3%

5.3%

Ctm

31.6%

36.8%

Ctm.

15.8%

52.6%

Pct

15.8%

68.4%

Pct.

15.8%

84.2%

Ranitidine

15.8%

100.0%

19

100.0%

100.0%

Total

95% Conf Limits

0.1%
12.6%
3.4%
3.4%
3.4%
3.4%

B. Com
Ctm
Ctm.
Pct
Pct.
Ranitidine

26.0%
56.6%
39.6%
39.6%
39.6%
39.6%

Obat4
Back Forward Current Procedure
Obat4
Frequency

Percent

Cum Percent

Amox

16.7%

16.7%

Amox Cyrup

16.7%

33.3%

GG

66.7%

100.0%

Total

100.0%

100.0%

Amox
Amox Cyrup
GG

95% Conf Limits

0.4%
0.4%
22.3%

64.1%
64.1%
95.7%

JenisJaminanKesehatan
Back Forward Current Procedure
JenisJaminanKesehatan
Frequency

Percent

Cum Percent

ASKES

16.7%

16.7%

BPJS

30.0%

46.7%

JAMKESDA

30.0%

76.7%

JAMKESMAS

23.3%

100.0%

30

100.0%

100.0%

Total

ASKES
BPJS
JAMKESDA
JAMKESMAS

95% Conf Limits

5.6%
14.7%
14.7%
9.9%

34.7%
49.4%
49.4%
42.3%